OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fluid homeostasis induced by sodium-glucose cotransporter 2 inhibitors: novel insight for better cardio-renal outcomes in chronic kidney disease
Takahiro Masuda, Daisuke Nagata
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1195-1201
Closed Access | Times Cited: 13
Takahiro Masuda, Daisuke Nagata
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1195-1201
Closed Access | Times Cited: 13
Showing 13 citing articles:
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction
Maki Asakura-Kinoshita, Takahiro Masuda, Kentaro Oka, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1194-1194
Open Access | Times Cited: 4
Maki Asakura-Kinoshita, Takahiro Masuda, Kentaro Oka, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1194-1194
Open Access | Times Cited: 4
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)
Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
2023 update and perspectives
Masaki Mogi, Atsushi Tanaka, Koichi Node, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 6-32
Closed Access | Times Cited: 8
Masaki Mogi, Atsushi Tanaka, Koichi Node, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 6-32
Closed Access | Times Cited: 8
Polypill Therapy for Cardiovascular Disease Prevention and Combination Medication Therapy for Hypertension Management
Keisuke Narita, Satoshi Hoshide, Kazuomi Kario
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7226-7226
Open Access | Times Cited: 8
Keisuke Narita, Satoshi Hoshide, Kazuomi Kario
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7226-7226
Open Access | Times Cited: 8
Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion
Akari Endo, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 33-45
Open Access | Times Cited: 7
Akari Endo, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 33-45
Open Access | Times Cited: 7
Fluid homeostatic action of dapagliflozin in patients with chronic kidney disease: the DAPA-BODY Trial
Kentaro Oka, Takahiro Masuda, Ken Ohara, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Kentaro Oka, Takahiro Masuda, Ken Ohara, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease
Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 628-638
Closed Access | Times Cited: 5
Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 628-638
Closed Access | Times Cited: 5
Water and sodium conservation response induced by SGLT2 inhibitor ipragliflozin in Dahl salt-sensitive hypertensive rats
Takahiro Masuda, Masahide Yoshida, Tatsushi Onaka, et al.
Hypertension Research (2024)
Closed Access | Times Cited: 1
Takahiro Masuda, Masahide Yoshida, Tatsushi Onaka, et al.
Hypertension Research (2024)
Closed Access | Times Cited: 1
Glomerular pressure and tubular oxygen supply: a critical dual target for renal protection
Takahiro Masuda, Daisuke Nagata
Hypertension Research (2024)
Closed Access | Times Cited: 1
Takahiro Masuda, Daisuke Nagata
Hypertension Research (2024)
Closed Access | Times Cited: 1
Central SGLT2 mediate sympathoexcitation in hypertensive heart failure via attenuating subfornical organ endothelial cGAS ubiquitination to amplify neuroinflammation: Molecular mechanism behind sympatholytic effect of Empagliflozin
Shutian Zhang, Yijun Huang, Chengzhi Han, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113711-113711
Closed Access | Times Cited: 1
Shutian Zhang, Yijun Huang, Chengzhi Han, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113711-113711
Closed Access | Times Cited: 1
From ashes to insights: decoding water and electrolyte balance in colitis
Yuichiro Arima
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 442-443
Open Access
Yuichiro Arima
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 442-443
Open Access
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study
Silvio Borrelli, Carlo Garofalo, Gianpaolo Reboldi, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 11
Open Access
Silvio Borrelli, Carlo Garofalo, Gianpaolo Reboldi, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 11
Open Access
Sodium glucose cotransporter 2 inhibitor as a promising therapy for congestive kidney injury
Kotaro Haruhara, Eisuke Kubo
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 568-570
Open Access
Kotaro Haruhara, Eisuke Kubo
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 568-570
Open Access
